Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Draper

Showing results (151-160 of 206) with videos related to

Pageof 21
Sort By:
Scientific Reports|August 23, 2017
Self-sorted Oligophenylvinylene and Perylene Bisimide HydrogelsAna M Castilla, Emily R Draper, Michael C Nolan, et al.
IJTLD Open|July 5, 2024
Acceptability of levofloxacin dispersible and non-dispersible tablet formulations in children receiving TB preventive treatmentD T Wademan, H R Draper, S E Purchase, et al.
Journal of Pharmaceutical Sciences|April 15, 2019
The Degradation Chemistry of Prasugrel Hydrochloride: Part 1-Drug SubstanceSteven W Baertschi, Lindsay Maxwell-Backer, Matthew Clemens, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 2, 2014
Pharmacokinetics and safety of moxifloxacin in children with multidrug-resistant tuberculosisStephanie Thee, Anthony J Garcia-Prats, Heather R Draper, et al.
Plos Medicine|May 1, 2019
Pharmacokinetics, optimal dosing, and safety of linezolid in children with multidrug-resistant tuberculosis: Combined data from two prospective observational studiesAnthony J Garcia-Prats, H Simon Schaaf, Heather R Draper, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 26, 2016
Outcome of culture-confirmed isoniazid-resistant rifampicin-susceptible tuberculosis in childrenA J Garcia-Prats, L du Plessis, H R Draper, et al.
AIDS Care|April 27, 2012
Evaluation of the effectiveness of an outreach clinical mentoring programme in support of paediatric HIV care scale-up in BotswanaGelane Workneh, Leah Scherzer, Brianna Kirk, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 23, 2018
Clinical and Cardiac Safety of Long-term Levofloxacin in Children Treated for Multidrug-resistant TuberculosisAnthony J Garcia-Prats, Heather R Draper, Heather Finlayson, et al.
The Pediatric Infectious Disease Journal|March 22, 2018
Effect of Coadministration of Lidocaine on the Pain and Pharmacokinetics of Intramuscular Amikacin in Children With Multidrug-Resistant Tuberculosis: A Randomized Crossover TrialAnthony J Garcia-Prats, Penelope C Rose, Heather R Draper, et al.
The Pediatric Infectious Disease Journal|December 15, 2018
Acceptability of a Novel Levofloxacin Dispersible Tablet Formulation in Young Children Exposed to Multidrug-resistant TuberculosisSusan E Purchase, Anthony J Garcia-Prats, Petra De Koker, et al.
Pageof 21

Showing results (151-160 of 206) with videos related to

Sort By:
Pageof 21
Scientific Reports|August 23, 2017
Self-sorted Oligophenylvinylene and Perylene Bisimide HydrogelsAna M Castilla, Emily R Draper, Michael C Nolan, et al.
IJTLD Open|July 5, 2024
Acceptability of levofloxacin dispersible and non-dispersible tablet formulations in children receiving TB preventive treatmentD T Wademan, H R Draper, S E Purchase, et al.
Journal of Pharmaceutical Sciences|April 15, 2019
The Degradation Chemistry of Prasugrel Hydrochloride: Part 1-Drug SubstanceSteven W Baertschi, Lindsay Maxwell-Backer, Matthew Clemens, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 2, 2014
Pharmacokinetics and safety of moxifloxacin in children with multidrug-resistant tuberculosisStephanie Thee, Anthony J Garcia-Prats, Heather R Draper, et al.
Plos Medicine|May 1, 2019
Pharmacokinetics, optimal dosing, and safety of linezolid in children with multidrug-resistant tuberculosis: Combined data from two prospective observational studiesAnthony J Garcia-Prats, H Simon Schaaf, Heather R Draper, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 26, 2016
Outcome of culture-confirmed isoniazid-resistant rifampicin-susceptible tuberculosis in childrenA J Garcia-Prats, L du Plessis, H R Draper, et al.
AIDS Care|April 27, 2012
Evaluation of the effectiveness of an outreach clinical mentoring programme in support of paediatric HIV care scale-up in BotswanaGelane Workneh, Leah Scherzer, Brianna Kirk, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 23, 2018
Clinical and Cardiac Safety of Long-term Levofloxacin in Children Treated for Multidrug-resistant TuberculosisAnthony J Garcia-Prats, Heather R Draper, Heather Finlayson, et al.
The Pediatric Infectious Disease Journal|March 22, 2018
Effect of Coadministration of Lidocaine on the Pain and Pharmacokinetics of Intramuscular Amikacin in Children With Multidrug-Resistant Tuberculosis: A Randomized Crossover TrialAnthony J Garcia-Prats, Penelope C Rose, Heather R Draper, et al.
The Pediatric Infectious Disease Journal|December 15, 2018
Acceptability of a Novel Levofloxacin Dispersible Tablet Formulation in Young Children Exposed to Multidrug-resistant TuberculosisSusan E Purchase, Anthony J Garcia-Prats, Petra De Koker, et al.
Pageof 21